Balance Sheet
Cash Flow Statement
AmortizationOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Depreciation & Amortization (CF) (2016 - 2022)

Historic Depreciation & Amortization (CF) for RedHill Biopharma (RDHL) over the last 11 years, with Q4 2022 value amounting to $491000.0.

  • RedHill Biopharma's Depreciation & Amortization (CF) rose 935.41% to $491000.0 in Q4 2022 from the same period last year, while for Dec 2023 it was $491000.0, marking a year-over-year decrease of 7701.31%. This contributed to the annual value of $31000.0 for FY2024, which is 9431.19% down from last year.
  • As of Q4 2022, RedHill Biopharma's Depreciation & Amortization (CF) stood at $491000.0, which was up 935.41% from $491000.0 recorded in Q3 2022.
  • In the past 5 years, RedHill Biopharma's Depreciation & Amortization (CF) registered a high of $617000.0 during Q2 2022, and its lowest value of $22000.0 during Q1 2018.
  • Over the past 5 years, RedHill Biopharma's median Depreciation & Amortization (CF) value was $433000.0 (recorded in 2020), while the average stood at $342350.0.
  • Per our database at Business Quant, RedHill Biopharma's Depreciation & Amortization (CF) tumbled by 1538.46% in 2018 and then soared by 120909.09% in 2019.
  • RedHill Biopharma's Depreciation & Amortization (CF) (Quarter) stood at $23000.0 in 2018, then skyrocketed by 1000.0% to $253000.0 in 2019, then surged by 86.96% to $473000.0 in 2020, then fell by 5.07% to $449000.0 in 2021, then grew by 9.35% to $491000.0 in 2022.
  • Its Depreciation & Amortization (CF) stands at $491000.0 for Q4 2022, versus $491000.0 for Q3 2022 and $617000.0 for Q2 2022.